Checkpoint Therapeutics, Inc. (CKPT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1232357,
    "name": "Checkpoint Therapeutics, Inc.",
    "stock_name": "Checkpoint Therapeutics, Inc.",
    "full_name": "Checkpoint Therapeutics, Inc.",
    "name_url": "stocks-analysis/checkpoint-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.26",
    "chg": 0.03,
    "chgp": "0.71%",
    "dir": 1,
    "prev_price": "4.23",
    "mcapval": "370.71",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals: Major",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US1628282063",
    "curr_date": "May 29",
    "curr_time": "",
    "bse_nse_vol": "17.33 M",
    "exc_status": "Active",
    "traded_date": "May 29, 2025",
    "traded_date_str": "2025 05 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/checkpoint-therapeutics-inc-1232357-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Checkpoint Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-checkpoint-therapeutics-inc-technically-bullish-or-bearish-3547574",
        "imagepath": "",
        "date": "2025-09-20 19:58:33",
        "description": "As of 14 April 2025, the technical trend for Checkpoint Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The weekly MACD, Bollinger Bands, KST, and OBV are all bullish, while the daily moving averages also confirm a bullish trend. The Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. \n\nIn terms of performance, the stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 33.12% compared to the S&P 500's 12.22%, and a one-year return of 132.79% versus 17.14%...."
      },
      {
        "title": "Is Checkpoint Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-checkpoint-therapeutics-inc-overvalued-or-undervalued-3543903",
        "imagepath": "",
        "date": "2025-09-20 18:32:12",
        "description": "As of 6 May 2021, the valuation grade for Checkpoint Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant downgrade in its investment appeal. The company appears to be overvalued given its high Price to Book Value of 22.75, an EV to Sales ratio of 337.66, and a negative ROE of -345.95%. In comparison, Journey Medical Corp. has a P/E of -18.6994 and Fortress Biotech, Inc. has a P/E of -1.1589, both indicating that Checkpoint is not competitively positioned within its peer group.\n\nDespite the overvaluation, Checkpoint Therapeutics has shown strong short-term performance, with a year-to-date return of 33.12%, significantly outperforming the S&P 500's 12.22%. However, the long-term outlook remains concerning, as the company has experienced a staggering -79.91% return over the past five years compared to the S&P 500's 96.61%...."
      }
    ],
    "total": 7,
    "sid": "1232357",
    "stock_news_url": "https://www.marketsmojo.com/news/checkpoint-therapeutics-inc-1232357"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Checkpoint Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:58:33

As of 14 April 2025, the technical trend for Checkpoint Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The weekly MACD, Bollinger Bands, KST, and OBV are all bullish, while the daily moving averages also confirm a bullish trend. The Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. In terms of performance, the stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 33.12% compared to the S&P 500's 12.22%, and a one-year return of 132.79% versus 17.14%....

Is Checkpoint Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:32:12

As of 6 May 2021, the valuation grade for Checkpoint Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant downgrade in its investment appeal. The company appears to be overvalued given its high Price to Book Value of 22.75, an EV to Sales ratio of 337.66, and a negative ROE of -345.95%. In comparison, Journey Medical Corp. has a P/E of -18.6994 and Fortress Biotech, Inc. has a P/E of -1.1589, both indicating that Checkpoint is not competitively positioned within its peer group. Despite the overvaluation, Checkpoint Therapeutics has shown strong short-term performance, with a year-to-date return of 33.12%, significantly outperforming the S&P 500's 12.22%. However, the long-term outlook remains concerning, as the company has experienced a staggering -79.91% return over the past five years compared to the S&P 500's 96.61%....

View All News